½ÃÀ庸°í¼­
»óǰÄÚµå
1304237

¿¬Çϰï¶õ °ü¸® ½ÃÀå : Á¦Ç°º°, ÀûÀÀÁõº°, À¯Åë ä³Îº°, Áö¿ªº° ½ÃÀå ±Ô¸ð, Á¡À¯À², Àü¸Á ¹× ±âȸ ºÐ¼®(2023-2030³â)

Dysphagia Management Market, By Product, By Indication, By Distribution channels, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¿¬Çϰï¶õÀº À½½ÄÀ̳ª ¼öºÐÀ» »ïŰ´Â µ¥ ¾î·Á¿òÀÌ ÀÖ´Â »óŸ¦ ¸»ÇÕ´Ï´Ù. ¿øÀÎÀ¸·Î´Â ÇÑ ÀÔÀÇ À½½ÄÀÌ ³Ê¹« Å©°Å³ª, Àß ¾ÃÁö ¸øÇϰųª, ÀÔ¾ÈÀÌ °ÇÁ¶Çϰųª, ¾àÀ» ¸Ô°Å³ª, ¸Å¿ì ¶ß°Å¿î À½½ÄÀ» ¸Ô¾úÀ» ¶§ µîÀÌ ÀÖ½À´Ï´Ù. ¿¬Çϰï¶õ¸¦ Ä¡·áÇϱâ À§ÇØ À½½ÄÀÇ Áú°¨À» º¯È­½ÃŰ´Â Á¦Ç°À̳ª »ïŰ±â ½¬¿î Æ©ºê µîÀ» »ç¿ëÇÕ´Ï´Ù. ¿¬Çϰï¶õ¸¦ Ä¡·áÇÏ´Â ¾à¹°µµ ÀÖÁö¸¸, ¸ðµç Áõ»óÀ» ¾à¹°·Î Ä¡·áÇÒ ¼ö ÀÖ´Â °ÍÀº ¾Æ´Õ´Ï´Ù. ¿¬Çϰï¶õÀº ¿¬Çϰï¶õÀÇ ÀÇÇÐÀûÀÎ ¸íĪÀÔ´Ï´Ù. ¿¬Çϰï¶õÀº À½½ÄÀ̳ª ¾×ü¸¦ ½±°Ô »ïų ¼ö ¾ø´Â »óŸ¦ ¸»ÇÕ´Ï´Ù. ¿¬Çϰï¶õÀÌ ÀÖ´Â »ç¶÷Àº À½½ÄÀ̳ª ¾×ü¸¦ »ïŰ·Á°í ÇÒ ¶§ ¸ñÀÌ ¸·Èú ¼ö ÀÖ½À´Ï´Ù. ¿¬Çϰï¶õÀº ±¸°­, ÀεÎ, ½Äµµ ¹× À§ ½É¿ÍºÎÀÇ ±â´ÉÀû ¶Ç´Â ±¸Á¶Àû ÀÌ»óÀ¸·Î ÀÎÇØ ¹ß»ýÇÒ ¼ö ÀÖÀ¸¸ç, ¿øÀο¡ µû¶ó ±Þ¼º ¶Ç´Â ¸¸¼ºÀ¸·Î ³ªÅ¸³¯ ¼ö ÀÖ½À´Ï´Ù. »õ·Î ¹ß»ýÇÏ´Â ¿¬Çϰï¶õÀº ½Äµµ¾ÏÀ̳ª µÎ°æºÎ¾ÏÀÇ °¡´É¼ºÀ» Æò°¡ÇØ¾ß ÇÏÁö¸¸, ´Ù¾çÇÑ ¾ç¼º Áúȯ°úµµ °ü·ÃÀÌ ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

½ÃÀåÀÇ ÁÖ¿ä ¾÷üµéµµ ȯÀÚ¸¦ À§ÇÑ °í±Þ ¸ð´ÏÅ͸µ¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖÀ¸¹Ç·Î °¡±î¿î ¹Ì·¡¿¡ ½ÃÀå ¼ºÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 10¿ù 17ÀÏ ¿µ±¹ ºê¸®Æ¼½Ã ¸ÞµðÄà Àú³Î (bmj)¿¡¼­ ¿¬Çϰï¶õ Á¶»ç¿¡ ´ëÇØ ¹ßÇ¥ ÇÑ ±â»ç¿¡¼­´Â ¿¬Çϰï¶õÀº ¸Ô°í ¸¶½Ã°í »ïŰ´Â °üÇà¿¡ ¾î·Á¿òÀ» °Þ´Â´Ù°í ¼³¸íÇÕ´Ï´Ù. ¿µ¾ç½ÇÁ¶¿Í ÈíÀμº Æó·ÅÀº ¾ç¼º ¶Ç´Â ¾Ç¼º ¿¬ÇÏÀå¾Ö·Î ÀÎÇØ ¹ß»ýÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ È¯ÀÚ´Â ÀϹÝÀûÀ¸·Î ´ÙÇÐÁ¦ °£ ÆÀ Ä¡·á°¡ ÇÊ¿äÇÕ´Ï´Ù. ¾ð¾î º´¸®ÇÐÀÚ´Â ¿¬ÇÏÀå¾ÖÀÇ Æò°¡ ¹× °ü¸®¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϸç, À½½Ä ¼·Ãë¿¡ ¹®Á¦°¡ ÀÖ´Â °æ¿ì ¿µ¾çÆÀ°ú Á¶±â¿¡ Çù·ÂÇØ¾ß ÇÕ´Ï´Ù.

Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • ÀÌ º¸°í¼­´Â ¼¼°è ¿¬Çϰï¶õ °ü¸® ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇßÀ¸¸ç, 2022³âÀ» ±âÁØ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2023-2030³â) ½ÃÀå ±Ô¸ð¿Í ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(6.2%)À» Á¦½ÃÇÕ´Ï´Ù.
  • ¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®ÀÇ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ÆÄ¾ÇÇϰí, ÀÌ ½ÃÀå¿¡ ´ëÇÑ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤ÅÃÇÑ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ °í·Á »çÇ×µµ Á¦°øÇÕ´Ï´Ù.
  • ¼¼°è ¿¬Çϰï¶õ °ü¸® ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, ¼º°ú ¹× Àü·«°ú °°Àº ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
  • ÀÌ Á¶»ç¿¡¼­ ´Ù·ç´Â ÁÖ¿ä ±â¾÷À¸·Î´Â Eisai Co. Ltd, C.R. Bard Inc.£¨Becton, Dickinson and Company£©, Hormel Health Labs, AstraZeneca, Cipla Ltd, Nestle Health Science, Kent Precision Food Group Inc., Bracco Diagnostics Inc., Phagenesis Ltd, Nutricia Advanced Medical Nutrition, Cook medical Inc.°¡ ÀÖ½À´Ï´Ù.
  • ÀÌ º¸°í¼­ÀÇ ÅëÂû·ÂÀ» ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ­, ½ÃÀå È®´ë ¹× ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
  • ¼¼°è ¿¬Çϰï¶õ °ü¸® ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ÀÌ »ê¾÷ÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚ´Â ¼¼°è ¿¬Çϰï¶õ °ü¸® ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ÀüÁ¦Á¶°Ç
  • ¾à¾î

Á¦2Àå ½ÃÀå »óȲ °³¿ä

  • º¸°í¼­ °³¿ä
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ½ÃÀå ±âȸ
  • ¿µÇ⠺м®
  • ÃÖ±ÙÀÇ Á¦Ç° Ãâ½Ã
  • ¿ªÇÐ
  • ÀμöÇÕº´(M&A) ¹× Çù¾÷
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • ÁÖ¿ä ¹ßÀü
  • PEST ºÐ¼®

Á¦4Àå ¼¼°èÀÇ ¿¬Çϰï¶õ °ü¸® ½ÃÀå - COVID-19ÀÇ ¿µÇ⠺м®

  • °æÁ¦Àû ¿µÇâ
  • COVID-19 ¿ªÇÐ
  • ¼ö±Þ¿¡ ´ëÇÑ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ¿¬Çϰï¶õ °ü¸® ½ÃÀå : Á¦Ç° À¯Çüº°, 2018³â-2030³â

  • ¾àÁ¦
  • Ç÷ÎÅæ ÆßÇÁ ÀúÇØÁ¦
  • °ø±Þ Æ©ºê
  • °æºñÀ§°ü
  • PEG Æ©ºê
  • ¿µ¾ç ¼Ö·ç¼Ç
  • ÁõÁ¡Á¦
  • À½·á
  • Ƕ·¹

Á¦6Àå ¼¼°èÀÇ ¿¬Çϰï¶õ °ü¸® ½ÃÀå, ÀûÀÀÁõº°, 2018-2030³â

  • ±¸°­ ¿¬Çϰï¶õ
  • ½Äµµ ¿¬Çϰï¶õ

Á¦7Àå ¼¼°èÀÇ ¿¬Çϰï¶õ °ü¸® ½ÃÀå : À¯Åë ä³Îº°, 2018³â-2030³â

  • º´¿ø ¾à±¹
  • ¼Ò¸Å ¾à±¹
  • µå·°½ºÅä¾î
  • Àü¹® Ŭ¸®´Ð

Á¦8Àå ¼¼°èÀÇ ¿¬Çϰï¶õ °ü¸® ½ÃÀå, Áö¿ªº°, 2018-2030³â

  • ºÏ¹Ì
  • ¹Ì±¹
  • ij³ª´Ù
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • ºê¶óÁú
  • ¸ß½ÃÄÚ
  • ¾Æ¸£ÇîÆ¼³ª
  • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • À¯·´
  • ¿µ±¹
  • µ¶ÀÏ
  • ÀÌÅ»¸®¾Æ
  • ÇÁ¶û½º
  • ½ºÆäÀÎ
  • ·¯½Ã¾Æ
  • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áß±¹
  • Àεµ
  • ÀϺ»
  • ASEAN
  • È£ÁÖ
  • Çѱ¹
  • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿
  • GCC
  • À̽º¶ó¿¤
  • ±âŸ Áßµ¿
  • ¾ÆÇÁ¸®Ä«
  • ºÏ¾ÆÇÁ¸®Ä«
  • Áß¾Ó¾ÆÇÁ¸®Ä«
  • ³²¾ÆÇÁ¸®Ä«

Á¦9Àå °æÀï ±¸µµ

  • Eisai Co. Ltd.
  • C.R. Bard Inc.(Becton, Dickinson and Company)
  • Hormel Health Labs
  • AstraZeneca
  • Cipla Ltd
  • Nestle Health Science
  • Kent Precision Food Group Inc.
  • Bracco Diagnostics Inc.
  • Phagenesis Ltd
  • Nutricia Advanced Medical Nutrition
  • Cook medical Inc.

Á¦10Àå ¼½¼Ç

  • Á¶»ç ¹æ¹ý
  • ÃâÆÇ»ç¿¡ ´ëÇØ
LSH 23.08.09

Dysphagia is characterized by difficulty swallowing food or liquids. The causes of the disease are large bites of food, insufficient chewing, dry mouth, pills or eating very hot food. Dysphagia treatment involves the use of products that change the texture of food and other products, such as tubes, to facilitate the swallowing process. Although, there are some medications to treat dysphagia, not all conditions can be treated with medication. Dysphagia is the medical name for difficulty swallowing. Swallowing difficulty is the inability to swallow foods or liquids with ease. People who have a hard time swallowing may choke on their food or liquid when trying to swallow. Dysphagia can be caused by functional or structural abnormalities of the oral cavity, pharynx, esophagus, or gastric cardia, and can be acute or chronic depending on the cause. New-onset dysphagia warrants evaluation for esophageal cancer and possibly head and neck cancer, but is also associated with a variety of benign conditions.

Market Dynamics

Major players in the market are also focused for the advanced monitoring for patients thus it is expected to drive the market growth in near future. For instance, on October 17, 2022 an article published by the British Medical Journal (the bmj), U.K on investigating dysphagia explains dysphagia describes difficulties with eating, drinking, and swallowing practices. Malnutrition and aspiration pneumonia can result from benign or malignant dysphagia. These patients usually require interdisciplinary team care. Speech-language pathologists play an important role in the evaluation and management of dysphagia and should be involved early with the nutrition team if there are concerns about food intake.

Key features of the study:

  • This report provides an in-depth analysis of the Global Dysphagia Management Market, and provides market size (US$ 4.4 billion) and compound annual growth rate (6.2%) for the forecast period (2023-2030), considering 2022 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global dysphagia management market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Eisai Co. Ltd, C.R. Bard Inc. (Becton, Dickinson and Company), Hormel Health Labs, AstraZeneca, Cipla Ltd, Nestle Health Science, Kent Precision Food Group Inc., Bracco Diagnostics Inc., Phagenesis Ltd, Nutricia Advanced Medical Nutrition, Cook medical Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The Global Dysphagia Management Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global dysphagia management market.

Detailed Segmentation:

  • Global Dysphagia Management Market, By Product Type:
  • Drug
    • Proton pump inhibitors
  • Feeding Tubes
    • Naso-Gastric
    • Tubes PEG tubes
  • Nutritional solutions
    • Thickener
    • Beverages
    • Purees
  • Global Dysphagia Management Market, By Indications :
    • Oropharangeal Dysphagia
    • Esophageal Dypshagia
  • Global Dysphagia Management Market, By Distribution channel:
    • Hospital pharmacies
    • Retail pharmacies
    • Drug store
    • Specialty clinics
  • Global Dysphagia Management Market, By Region:
  • North America
    • By Country:
  • U.S.
  • Canada
  • Latin America
    • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country:
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
  • Company Profiles
  • Eisai Co. Ltd
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • C.R. Bard Inc. (Becton, Dickinson and Company)
  • Hormel Health Labs
  • AstraZeneca
  • Cipla Ltd
  • Nestle Health Science
  • Kent Precision Food Group Inc.
  • Bracco Diagnostics Inc.
  • Phagenesis Ltd
  • Nutricia Advanced Medical Nutrition
  • Cook medical Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By Indication
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Product Launches
  • Epidemiology
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Dysphagia Management Market- COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Dysphagia Management Market, By Product Type, 2018-2030, (US$ Billion)

  • Overview
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Drug
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Proton pump inhibitors
  • Feeding Tubes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Naso-Gastric
  • Tubes PEG tubes
  • Nutritional solutions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Thickener
  • Beverages
  • Purees

6. Global Dysphagia Management Market, By Indications, 2018-2030, (US$ Billion)

  • Overview
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Oropharangeal Dysphagia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Esophageal Dysphagia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

7. Global Dysphagia Management Market, By Distribution Channel, 2018-2030, (US$ Billion)

  • Overview
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Hospital pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Retail pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Drug store
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Specialty clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

8. Global Dysphagia Management Market, By Region, 2018-2030, (US$ Billion)

  • Overview
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2018-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Billion)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Billion)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Billion)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Billion)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Billion)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Eisai Co. Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • C.R. Bard Inc. (Becton, Dickinson and Company)
  • Hormel Health Labs
  • AstraZeneca
  • Cipla Ltd
  • Nestle Health Science
  • Kent Precision Food Group Inc.
  • Bracco Diagnostics Inc.
  • Phagenesis Ltd
  • Nutricia Advanced Medical Nutrition
  • Cook medical Inc.

10. Section

  • Research Methodology
  • About Us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦